Free US stock portfolio analysis with expert recommendations for risk management and return optimization strategies designed for long-term success. We help you understand your current positioning and provide actionable steps to improve your overall investment performance. Our platform offers portfolio tracking, risk assessment, diversification analysis, and performance attribution tools. Optimize your investments with our comprehensive tools and expert guidance for consistent performance and risk-adjusted returns.
As of April 16, 2026, The Oncology Institute Inc. (TOI) is trading at $3.54, posting an intraday gain of 3.21% during regular market hours. This analysis examines key technical price levels for TOI, recent market context for the specialty oncology care sector, and potential short-term price scenarios that market participants may monitor. No recently released quarterly earnings data is available for TOI at the time of writing, so current price action is largely being driven by technical flows and
The (TOI) Stock: Valuation Metrics (+3.21%) 2026-04-16 - Analyst Recommended Stocks
TOI - Stock Analysis
3491 Comments
952 Likes
1
Rikyah
Daily Reader
2 hours ago
I canโt believe I overlooked something like this.
๐ 162
Reply
2
Janyssa
Influential Reader
5 hours ago
I canโt be the only one looking for answers.
๐ 176
Reply
3
Daivian
Influential Reader
1 day ago
Short-term consolidation may lead to a fresh breakout.
๐ 214
Reply
4
Salyna
Experienced Member
1 day ago
Professional US stock economic sensitivity analysis and beta calculations to understand market correlation and risk exposure. We help you position your portfolio appropriately based on your risk tolerance and market outlook.
๐ 58
Reply
5
Cary
Influential Reader
2 days ago
Missed it completelyโฆ sigh.
๐ 199
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.